Chinese Medical Journal (Jul 2022)

Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)

  • Fengjiang Qu,
  • Di Wu,
  • Yunjiang Liu,
  • Wei Gao,
  • Shu Wang,
  • Siyuan Wang,
  • Feng Jin,
  • Bo Chen,
  • Jian Huang,
  • Shanshan Sun,
  • Zhimin Fan,
  • Chinese Society of Breast Surgery,
  • Yanjie Yin,
  • Xiuyuan Hao

DOI
https://doi.org/10.1097/CM9.0000000000002309
Journal volume & issue
Vol. 135, no. 14
pp. 1753 – 1755

Abstract

Read online

No abstracts available.